Back to top
more

BioAge Labs, Inc. (BIOA)

(Real Time Quote from BATS)

$4.39 USD

4.39
57,481

+0.27 (6.55%)

Updated Aug 4, 2025 03:36 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (143 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks News

Zacks Equity Research

BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

BioAge Labs, Inc. (BIOA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Biotech Stock Roundup: BIOA Down on Study Update, QURE, CRDF Gain on Study Data & More

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news also continued to be in the spotlight.

Sweta Killa headshot

Top Stories of Q1 From Wall Street

We discuss some of the events that dominated the headlines in 1Q and influenced stock movement.

    Zacks Equity Research

    Will Toyota (TM) Disappoint Investors this Earnings Season?

    Toyota Motor Corporation (TM) is set to report the fourth quarter and fiscal 2017 (ended Mar 31, 2017) results on May 10.

      Zacks Equity Research

      American Vanguard (AVD) Looks Good: Stock Moves 6.3% Higher

      American Vanguard Corporation (AVD) shares rose above 6% in the last trading session.

        Zacks Equity Research

        Valvoline Now a Strong Buy on Inorganic Prospects, '17 View

        On Mar 18, Zacks Investment Research upgraded Valvoline Inc. (VVV) to a Zacks Rank #1 (Strong Buy).

          Zacks Equity Research

          KMG Chemicals Upgraded to Strong Buy on Bright Prospects

          Zacks Investment Research upgraded KMG Chemicals, Inc. (KMG) to a Zacks Rank #1 (Strong Buy) on Mar 15, 2017.

            Zacks Equity Research

            KMG Chemicals Hits 52-Week High on Solid Q1, Bright Future

            Shares of KMG Chemicals, Inc. (KMG) reached a 52-week high of $40.07 during its trading session on Dec 27. This apex improved upon the last 52-week high of $39.25 on Dec 23.

              Zacks Equity Research

              International Flavors' Future Prospects Bright, Runs Risks

              We issued an updated research report on International Flavors & Fragrances Inc. (IFF) on Dec 12, 2016.